Oppenheimer & Co’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5M Buy
148,913
+5,410
+4% +$820K 0.26% 66
2025
Q4
$20.6M Buy
143,503
+4,515
+3% +$666K 0.29% 58
2025
Q3
$21.4M Sell
138,988
-7,114
-5% -$1.11M 0.26% 70
2025
Q2
$23.3M Buy
146,102
+1,567
+1% +$256K 0.31% 55
2025
Q1
$24.6M Sell
144,535
-3,396
-2% -$569K 0.37% 43
2024
Q4
$24.8M Buy
147,931
+1,513
+1% +$258K 0.37% 45
2024
Q3
$25.4M Sell
146,418
-3,705
-2% -$629K 0.39% 40
2024
Q2
$24.8M Sell
150,123
-1,423
-0.9% -$233K 0.39% 40
2024
Q1
$24.6M Sell
151,546
-2,191
-1% -$344K 0.41% 40
2023
Q4
$22.5M Sell
153,737
-1,446
-0.9% -$214K 0.41% 38
2023
Q3
$22.6M Sell
155,183
-2,825
-2% -$432K 0.47% 32
2023
Q2
$24M Buy
158,008
+3,536
+2% +$533K 0.48% 30
2023
Q1
$23M Sell
154,472
-3,180
-2% -$455K 0.49% 32
2022
Q4
$23.9M Sell
157,652
-6,166
-4% -$864K 0.54% 26
2022
Q3
$20.7M Sell
163,818
-14,417
-8% -$2.05M 0.48% 30
2022
Q2
$25.6M Buy
178,235
+10,043
+6% +$1.51M 0.55% 24
2022
Q1
$25.7M Sell
168,192
-2,291
-1% -$358K 0.46% 31
2021
Q4
$27.9M Sell
170,483
-523
-0.3% -$77.7K 0.49% 26
2021
Q3
$23.9M Sell
171,006
-1,804
-1% -$256K 0.45% 32
2021
Q2
$23.3M Buy
172,810
+3,298
+2% +$446K 0.42% 33
2021
Q1
$23M Buy
169,512
+2,131
+1% +$278K 0.46% 33
2020
Q4
$23.3M Buy
167,381
+4,330
+3% +$605K 0.49% 33
2020
Q3
$22.7M Sell
163,051
-4,007
-2% -$532K 0.57% 27
2020
Q2
$20M Sell
167,058
-9,545
-5% -$1.11M 0.52% 36
2020
Q1
$19.4M Sell
176,603
-276
-0.2% -$33.1K 0.59% 33
2019
Q4
$22.1M Buy
176,879
+6,823
+4% +$835K 0.55% 34
2019
Q3
$21.2M Sell
170,056
-5,681
-3% -$671K 0.58% 33
2019
Q2
$19.3M Buy
175,737
+331
+0.2% +$35.3K 0.52% 34
2019
Q1
$18.3M Sell
175,406
-990
-0.6% -$96.4K 0.49% 40
2018
Q4
$16.2M Sell
176,396
-4,887
-3% -$437K 0.51% 39
2018
Q3
$15.1M Sell
181,283
-10,245
-5% -$838K 0.38% 54
2018
Q2
$14.9M Buy
191,528
+14,828
+8% +$1.12M 0.41% 52
2018
Q1
$14M Buy
176,700
+6,075
+4% +$506K 0.36% 60
2017
Q4
$15.7M Sell
170,625
-4,516
-3% -$406K 0.4% 50
2017
Q3
$15.9M Buy
175,141
+2,107
+1% +$192K 0.43% 50
2017
Q2
$15.1M Sell
173,034
-8,029
-4% -$708K 0.42% 45
2017
Q1
$16.3M Sell
181,063
-8,562
-5% -$759K 0.46% 42
2016
Q4
$15.9M Sell
189,625
-13,659
-7% -$1.16M 0.46% 46
2016
Q3
$18.2M Buy
203,284
+2,624
+1% +$228K 0.53% 36
2016
Q2
$17M Sell
200,660
-60,461
-23% -$4.96M 0.51% 36
2016
Q1
$21.5M Buy
261,121
+13,420
+5% +$1.08M 0.65% 20
2015
Q4
$19.7M Buy
247,701
+19,970
+9% +$1.53M 0.59% 28
2015
Q3
$16.4M Sell
227,731
-1,570
-0.7% -$118K 0.5% 38
2015
Q2
$17.9M Sell
229,301
-11,137
-5% -$896K 0.5% 36
2015
Q1
$19.7M Buy
240,438
+10,708
+5% +$921K 0.54% 31
2014
Q4
$20.9M Sell
229,730
-4,083
-2% -$359K 0.6% 27
2014
Q3
$19.6M Buy
233,813
+17,656
+8% +$1.45M 0.58% 27
2014
Q2
$17M Sell
216,157
-58,736
-21% -$4.74M 0.51% 31
2014
Q1
$22.2M Buy
274,893
+50,181
+22% +$3.95M 0.66% 23
2013
Q4
$18.3M Sell
224,712
-6,743
-3% -$549K 0.59% 27
2013
Q3
$17.5M Buy
231,455
+15,625
+7% +$1.24M 0.62% 25
2013
Q2
$16.6M Buy
+215,830
New +$16.9M 0.64% 21

Other funds holding PG

Oppenheimer & Co's PG Position: Q1 2026 in Review

Oppenheimer & Co increased its Procter & Gamble (PG) stake by 3.8% in Q1 2026, buying an estimated $820K and bringing the position to 148,913 shares worth $21.5M. The position accounts for 0.26% of the portfolio, ranked #66.

Oppenheimer & Co first reported a position in PG in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.9M in Q4 2021. 3,987 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Oppenheimer & Co held 148,913 shares of Procter & Gamble worth $21.5M as of Q1 2026.
  • Oppenheimer & Co bought 5,410 Procter & Gamble shares in Q1 2026, an estimated $820K.
  • Procter & Gamble made up 0.26% of Oppenheimer & Co's portfolio in Q1 2026, its #66 holding.
  • Oppenheimer & Co first reported a position in Procter & Gamble in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Procter & Gamble position peaked at $27.9M in Q4 2021.
  • 3,987 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.